|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received October 7, 2003
Revised October 31, 2003
Accepted after revision November 27, 2003
1 University of Texas-Houston
2 SUNY
* To whom correspondence should be addressed. E-mail: mslaught{at}buffalo.edu.
Retinal ganglion cells exhibit fast and slow inhibitory synaptic glycine currents that can be selectively inhibited by strychnine and 5,7-dichlorokynurenic acid (DCKA), respectively. In this study we examined whether strychnine and DCKA selectivity correlated with the subunit composition of the glycine receptor. Homomeric alpha1, alpha2 or alpha2* glycine subunits were in vitro expressed in human embryonic kidney cells (HEK 293). In cells expressing the alpha1 subunit, responses to 200 & [mu]M glycine were blocked by 1 µM strychnine but not by 500 µM DCKA. In cells expressing the alpha2 subunit, both 1 µM strychnine and 500 µM DCKA were effective antagonists of 200 iM glycine. In cells expressing alpha2* subunits, which are much less glycine sensitive, 10 mM glycine was inhibited by 500 µM DCKA but not by 1 µM strychnine. A single amino acid mutation in the alpha1 subunit (R196G), converted this subunit from DCKA-insensitive to DCKA-sensitive. In conclusion, the comparative effectiveness of strychnine and DCKA can be used to distinguish between the alpha1, alpha2, and alpha2* receptor responses. Furthermore, a single amino acid near the glycine receptor's putative agonist binding site may account for differences in DCKA sensitivity amongst the alpha subunits.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |